Regression of choroidal metastasis secondary to breast carcinoma with adjuvant intravitreal injection of bevacizumab

Acta Ophthalmologica

Volumn 88, Issue 7, 2010, Pages

  Yao, Hsin Yu ^a   Horng, Chi Ting ^b   Chen, Jiann Torng ^a   Tsai, Ming Ling ^a,c  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; BREAST CARCINOMA; CASE REPORT; CHOROIDAL METASTASIS; CLINICAL FEATURE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LYMPH NODE DISSECTION; METASTASIS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CARCINOMA; CHOROID NEOPLASMS; FEMALE; HUMANS; INJECTIONS, INTRAOCULAR; MIDDLE AGED; TREATMENT OUTCOME; VITREOUS BODY;

EID: 78349279995     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01684.x     Document Type: Letter

References (5)

1. Amselem L, Cervera E, Díaz-Llopis M, Montero J, Garcia-Pous M, Udaondo P, Garcia-Delpech S, &, Salom D, (2007): Intravitreal bevacizumab (Avastin) for choroidal metastasis secondary to breast carcinoma: short-term follow-up. Eye 21: 566 - 567.
2. Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP, Alberts SR, Schwartz MA, &, Benson AB, III, (2007): Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25: 1539 - 1544.
3. Kanthan GL, Jayamohan J, Yip D, &, Conway RM, (2007): Management of metastatic carcinoma of the uveal tract: an evidence-based analysis. Clin Experiment Ophthalmol 35: 553 - 565.
4. Kuo IC, Haller JA, Maffrand R, Sambuelli RH, &, Reviglio VE, (2008): Regression of a subfoveal choroidal metastasis of colorectal carcinoma after intravitreous bevacizumab treatment. Arch Ophthalmol 126: 1311 - 1313.
5. Miller K, Wang M, Gralow J, Dickler M, Cobleigh M, Perez EA, Shenkier T, Cella D, &, Davidson NE, (2007): A randomized phase III trial of paclitaxel versus paclitaxel plus bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group (E2100). N Engl J Med 357: 2666 - 2676.